| scholarly article | Q13442814 |
| P2093 | author name string | Johnson PM | |
| Ledger WL | |||
| Lockwood GM | |||
| Birdsall MA | |||
| Chamley LW | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 1185-1189 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Human Reproduction | Q5937357 |
| P1476 | title | Antiphospholipid antibodies in women having in-vitro fertilization | |
| P478 | volume | 11 |
| Q28198928 | A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies |
| Q61837014 | Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study |
| Q36527050 | Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage |
| Q73470874 | Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis |
| Q73399951 | Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients |
| Q36267538 | Antiphospholipid antibodies associated with implantation failure after IVF/ET. |
| Q35174093 | Antiphospholipid antibodies in implantation failures |
| Q41682862 | Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss |
| Q28193967 | Antiphospholipid antibodies: biological basis and prospects for treatment |
| Q78759642 | Antiphospholipid antibody round table report |
| Q28182092 | Antiphospholipid syndrome and recurrent miscarriages |
| Q28196482 | Antiphospholipid syndrome in obstetrics |
| Q41561833 | Autoantibodies and infertility: a review of the literature |
| Q41591264 | Autoantibody screening for infertility: explaining the unexplained? |
| Q40213844 | Controlled ovarian hyperstimulation changes the prevalence of serum autoantibodies in in vitro fertilization patients |
| Q37984847 | Does immunotherapy for treatment of reproductive failure enhance live births? |
| Q35931281 | Drug intervention in early pregnancy after assisted reproductive technology |
| Q50650096 | IgG-antiphospholipid antibodies in follicular fluid of IVF-ET patients are related to low fertilization rate of their oocytes. |
| Q43921378 | Immunoglobulins and cytokines level in follicular fluid in relation to etiology of infertility and their relevance to IVF outcome |
| Q74269310 | Immunologic tests and IVF: "Please, enough already" |
| Q55266406 | Impact of presence of antiphospholipid antibodies on in vitro fertilization outcome. |
| Q53583026 | Influence of antiphospholipid antibodies on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer. |
| Q28195646 | Low molecular weight heparin in immunological recurrent abortion--the incredible cure |
| Q28220366 | Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis |
| Q46196782 | Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial |
| Q73550802 | Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome |
| Q43926851 | Ovulation induction, lupus and antiphospholipids |
| Q34173981 | Placentation, antiphospholipid syndrome and pregnancy outcome |
| Q51559345 | Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. |
| Q77664361 | Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization |
| Q73479928 | Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization |
| Q33331152 | Pretreatments before the induction of ovulation in assisted reproduction technologies: evidence-based medicine in 2007. |
| Q37388712 | Prophylaxis of VTE in women - during assisted reproductive techniques |
| Q28192087 | Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple |
| Q34108983 | Treatment of the antiphospholipid antibody syndrome: progress in the last five years? |
| Q84600099 | [Hormone therapy, fertility and pregnancy in antiphospholipid syndrome] |
Search more.